PUD Flashcards

1
Q

3 common forms of PUD

A

H. pylori positive
NSAID-induced
Stress related mucosal damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

H. pylori site of damage

A

duodenum

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

NSAID site of damage

A

stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

stress related site of damage

A

stomach

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

which type of PUD is more dependent on pH

A

H. pylori

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

which type/s of PUD are asymptomatic

A

NSAID

stress related

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

which type of PUD has deep ulcers

A

NSAID

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe GI bleeding associated with H. pylori

A

less severe

single vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

describe GI bleeding associated with NSAID

A

more severe

single vessel

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

describe GI bleeding associated with stress

A

more severe

superficial mucosal capillaries

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

PUD risk factors

A
H. pylori 
NSAIDs
Stress
Gastric acid hypersecretion 
Cigarette smoking
Diet
Chronic diseases
Vascular insufficiency
Chemo/radiation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Risk factors for NSAID induced ulcer

A
age >65
previous peptic ulcer, ulcer-related complications
high dose NSAIDs
Multiple NSAIDs
Selection of NSAID
Use of ASA, bisphosphonates, corticosteroids, anticoagulants, antiplatelets, SSRIs
chronic debilitating disorders
H. pylori infection
Smoking
Alcohol
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Name nonselective NSAIDs

A
indomethacin
piroxicam
ibuprofen 
naproxen
sulindac
ketoprofen
ketorolac
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

name partially selective NSAIDs

A

etodolac
meloxicam
nabumetone
diclofenac

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

PUD complications

A

Upper GI bleed
Perforation
Obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

PUD complications

A

Upper GI bleed
Perforation
Obstruction

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

PUD clinical presentation

A

Epigastric pain
Nocturnal pain
Duodenal ulcer (1-3 hours after eating, aggrevated by food)
Gastric ulcer (resolved by food)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Urease test requirements

A

Endoscopic
no PPIs x 2 weeks
no antibiotics/bismuth salts x 4 weeks

19
Q

4 non-pharm treatments for PUD

A

reduce stress
smoking cessation
d/c NSAIDs
avoid aggrevating food/beverages

20
Q

H2RA MOA

A

reversible inhibition of histamine receptor on parietal cells - acid production reduced 70%

21
Q

Famotidine dosing

A

20 mg IV/PO BID or 40 mg HS

22
Q

Famotidine dosing renal

A

CrCl

23
Q

Ranitidine dosing

A

150 mg PO BID or 300 mg HS

50 mg IV Q6-8 hours

24
Q

Ranitidine dosing renal

A

CrCl

25
Q

H2RA AEs

A

Tolerance develops quickly
Thrombocytopenia
Neuro effects: somnolence, HA

26
Q

PPI MOA

A

irreversibly inhibit proton pump, reduce acid up to 99%

27
Q

Omeprazole dosing

A

20-40 mg PO daily

28
Q

Esomeprazole dosing

A

40 mg PO/IV daily

29
Q

Pantoprazole dosing

A

40 mg PO/IV daily

30
Q

PPI AEs

A
Fractures
C. diff
Pneumonia
Thrombocytopenia
GI upset (N/V/D)
31
Q

Antacids MOA

A

neutralize gastric acid
inhibit action of peptin
no effect on acid production

32
Q

Antacids AEs

A

GI upset - diarrhea (magnesium), constipation (calcium)
Accumulation in renal dysfunction -> toxicity
frequent administration
drug interactions

33
Q

Antacids AEs

A

GI upset - diarrhea (magnesium), constipation (calcium)
Accumulation in renal dysfunction -> toxicity
frequent administration
drug interactions

34
Q

Sucralfate MOA

A

forms polyvalent bonds with damaged tissue and normal GI mucosa

35
Q

Sucralfate AEs

A
Aluminum toxicity 
Cheap
Decreased risk of pneumonia
PO only 
Drug interactions
Constipation
Frequent administration
36
Q

Misoprostol MOA

A

inhibits gastric acid secretion, increase in mucosal defense

synthetic prostaglandin analog

37
Q

Misoprostol AEs

A

diarrhea
abdominal cramping
N/V

38
Q

Misoprostal preg cat

A

X

39
Q

Bismuth subsalicylate MOA

A

antibacterial effect
local gastroprotective effect
stimulation of endogenous prostaglandins

40
Q

Bismuth subsalicylate AEs

A

Discoloration of the tongue
Gray/Black stools
tinnitus

41
Q

Bismuth subsalicylate AEs

A

Discoloration of the tongue
Gray/Black stools
tinnitus

42
Q

When is 14 day therapy for treatment of H. pylori preferred

A

1st line 3 drug regimen and recurrence

43
Q

duration of therapy for treatment of H. pylori

A

10-14 days